Skip to content
bluejethealthcare.com
Home
About Us
At A Glance
Facilities
History
Sustainability
News And Media
Business Segments
Integrated Contrast Media Intermediate Manufacturer
Saccharin & it’s salts
Niche pharmaceutical intermediates & API
CDMO-CMO
Capabilities
EHS
Reaction Capabilities
R & D Capabilities
Manufacturing Capabilities
Contact
Careers
Investor Relations
Notices
Investor Presentation
Stock Exchange Communication
Financial information
Annual Report
Annual Return
Corporate Governance
Board of Directors
Board Committees
Governance Policies
Familiarization Programmes
Prospectus
Investors Contact
Regulation 46 SEBI LODR
Shareholding Pattern
Tax Exemption Registration
AGM / EGM
Menu
Home
About Us
At A Glance
Facilities
History
Sustainability
News And Media
Business Segments
Integrated Contrast Media Intermediate Manufacturer
Saccharin & it’s salts
Niche pharmaceutical intermediates & API
CDMO-CMO
Capabilities
EHS
Reaction Capabilities
R & D Capabilities
Manufacturing Capabilities
Contact
Careers
Investor Relations
Notices
Investor Presentation
Stock Exchange Communication
Financial information
Annual Report
Annual Return
Corporate Governance
Board of Directors
Board Committees
Governance Policies
Familiarization Programmes
Prospectus
Investors Contact
Regulation 46 SEBI LODR
Shareholding Pattern
Tax Exemption Registration
AGM / EGM
Financial Year 2023-24
BRSR- 2023-24
Annual Report 2023-24
Quarterly Results
Financials March 2024
Financials December 2023
Financials September 2023
Financials June 2023
Financial Year 2022-23
Standalone Annual Report FY 22-23
Financial Year 2021-22
Standalone Annual Report FY 21-22
Financial Year 2020-21
Consolidated Annual Report FY 20-21
Standalone Annual Report FY 20-21
Scroll to Top
